Biological and clinical advances in stem cell expansion

Leukemia

Volumn 10, Issue 6, 1996, Pages 943-945

  Lange, W ^a   Henschler, R ^a   Mertelsmann, R ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cytokines; Ex vivo expansion; Peripheral blood progenitor cells

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR;

CANCER CHEMOTHERAPY; CELL PROLIFERATION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SHORT SURVEY; STEM CELL TRANSPLANTATION;

EID: 0030057805     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (21)

1. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM. Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 1992; 339: 640-644.
2. To LB, Roberts MM, Haylock DN, Dyson PG, Branford AL, Thorp D, Ho JQK, Dart GW, Horvath N, Davy MLJ, Olweny CLM, Abdi E, Juttner CA. Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
3. Brugger W, Birken R, Bertz H, Hecht T, Frisch J, Schulz G, Mertelsmann R, Kanz L. Peripheral blood progenitor cells mobilized by chemotherapy + G-CSF accelerate both neutrophil and platelet recovery after high dose VP16, ifosfamide and cisplatin. Br J Haematol 1993; 84: 402-407.
4. Brugger W, Bross KJ, Frisch J, Dern P, Weber B, Mertelsmann R, Kanz L. Mobilization of peripheral blood progenitor cells by sequential administration of IL-3 and GM-CSF following polychemotherapy with etoposide, ifosfamide and cisplatin. Blood 1992; 79: 1193-1200.
5. Schneider JG, Crown J, Shapiro F, Reich L, Hoskins I, Hakes T, Norton L, Moore MAS. Ex vivo cytokine expansion of CD34-positive hematopoietic progenitors in bone marrow (BM), placental cord blood (CB), and cyclophosphamide and G-CSF mobilized peripheral blood (PB). Blood 1992; 80 (Suppl.): 268a.
6. + cells into the myeloid lineage. Blood 1992; 80: 1405-1412.
7. + progenitor cells by stem cell factor, interleukin-1 β, IL-6, IL-3, interferon-gamma, and erythropoietin. Blood 1993; 81: 2579-2584.
8. + cells from patients with stage IV breast cancer. Blood 1994; 84: 3567-3574.
9. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 1994; 84: 1421-1426.
10. +-selected human peripheral blood progenitor cells. Blood 1994; 84: 2898-2903.
11. Sutherland HJ, Eaves CJ, Lansdorp PM, Thacker JD, Hogge DE. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood 1991; 78: 666-672.
12. Verfaillie CM, Catanzarro PM, Li WN. Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J Exp Med 1994; 179: 643-649.
13. - cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3-supplemented 'stroma-noncontact' cultures are highly enriched for long-term bone marrow culture initiating cells. Blood 1994; 84: 1442-1449.
14. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. New Engl J Med 1995; 333 283-287.
15. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109-1118.
16. 1,2. J Immunol 1995; 154: 5851-5861.
17. Gabbianelli M, Pelosi E, Montesoro E, Valtieri M, Luchetti L, Samoggia P, Vitelli L, Barberi T, Testa U, Lyman S, Peschle C. Multilevel effects of flt 3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors. Blood 1995; 86: 1661-1670.
18. Koller MR, Emerson SG, Palsson BO. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 1993; 82: 378-384.
19. Koller MR, Manchel I, Newsom BS, Palsson MA, Palsson BO. Bioreactor expansion of human bone marrow: comparison of unprocessed, density-separated, and CD34-enriched cells. J Hematother 1995; 4: 159-169.
20. Mulligan R. The basic science of gene therapy. Science 1993; 260: 926-932.
21. Merrouche Y, Favrot M. Retroviral gene therapy and its application in oncohematology. Hum Gene Ther 1992; 3: 285-291.